As legal professionals working in healthcare, the week of November 27, 2023, demands notable attention for various reasons. Emerging from the Thanksgiving break, Congress is reenergizing its efforts to move important priority items forward. While the spotlight is primarily on non-healthcare-related matters such as Israel’s funding, Ukraine’s funding, and passing the annual defense authorization bill (NDAA), tides can change swiftly.
According to a report by McDermott+Consulting, there is no year-end government funding package anticipated this year. However, the upcoming weeks are slated to be bustling with Congressional activity, emphasizing the significance of staying abreast of the developments.
In the gray area where healthcare intersects with geopolitical issues and defense budgets, it is crucial to maintain a keen eye on the unfolding events. It is well established that developments in different sectors can have significant ripple effects on healthcare policy and regulations.
Considering the limited time before the year ends and January 19’s impending legislative deadlines, a dramatic ramp-up in activity across Congress is predicted. These actions could turn the tides in an unanticipated direction, potentially impacting the healthcare industry.
As we continue to observe and analyze Congress’s moves in the weeks to come, what remains pivotal is the flexibility to adapt to any sudden changes in current priorities. While healthcare is not leading the charge in the agenda, a space worth watching is the potential for matters that initially seem unrelated to link back to healthcare policy transformations.
To summarize, even in a week where healthcare isn’t topping the Congressional agenda, it is paramount that those within the sector stay informed and ready for any potential regulatory changes. Continual vigilance and readiness to respond to changes highlight this period of potential legislative flux.